BiVol 4th-generation breast augmentation — a symbolic sculptural image of ADM-scaffold–based, implant-free autologous tissue augmentation developed by Bong Bong Plastic Surgery Clinic

BiVol · 4th-Generation Breast Augmentation · Developed by Bong Bong Plastic Surgery · KIPO Trademark Registered

For decades, breast augmentation has evolved around the silicone implant. From the first-generation saline devices, to second-generation smooth-surface implants, to third-generation textured cohesive-gel implants — each generation refined its predecessor, yet fundamental issues remained: foreign-body sensation, capsular contracture, and periodic replacement.

BiVol, developed by Bong Bong Plastic Surgery, begins from a different question: "Rather than perfecting the implant, could we build a breast without an implant at all?" This article walks through the science behind BiVol, the practical differences compared to conventional implants, and who might be the right candidate.

The 3-minute summary

Procedure
BiVol · 4th-Generation Breast Augmentation
Core principle
No silicone implant. Uses ADM and other biocompatible materials that are gradually replaced by the body's own tissue.
Surgery time
About 60 minutes · general anesthesia · same-day discharge
Return to daily life
Within 3–5 days (sutures removed at day 7)
Official registration
Trademark registered with the Korean Intellectual Property Office (KIPO)

What is BiVol?

BiVol is a world-first 4th-generation breast augmentation technique, developed by Bong Bong Plastic Surgery and trademark-registered by the Korean Intellectual Property Office (KIPO)1. Instead of inserting a silicone implant, BiVol individually designs and places biocompatible Acellular Dermal Matrix (ADM) and related biomaterials tailored to each patient's body2.

The most important feature is that these biomaterials are gradually replaced by the patient's own tissue over time. Immediately after surgery, the placed ADM provides volume; but over the following months, the body regenerates collagen and native tissue in its place — until the augmented volume becomes genuinely part of "your own body." Detailed technical documentation and academic publications are available at the official BiVol website (bivol.co.kr).

Not the age of implants, but the age when the body builds its own volume. BiVol is the first sentence of that chapter.

Dr. Seongsoo Park · Chief Director, Bong Bong Plastic Surgery Clinic

Why "4th generation"?

Breast augmentation has evolved along the following trajectory:

  1. Generation 1 — The dawn of silicone implants. Limited safety and naturalness.
  2. Generation 2 — Smooth-surface cohesive-gel implants. Improved feel.
  3. Generation 3 — Textured and nano-surface implants. Reduced capsular contracture risk.
  4. Generation 4 (BiVol) — No implant is used at all. A biomaterial approach that gradually converts to the patient's own tissue.

While earlier generations improved the "material" of the implant, the 4th generation redefines the concept of the material itself. Rather than inserting a foreign object, BiVol provides a scaffold that guides the body to build its own tissue — that is the core philosophy of BiVol.

For context, Hybrid Augmentation Mammoplasty, which corresponds to the third generation, combines an implant with autologous fat grafting — a technique for which Dr. Seongsoo Park published the first Korean paper in 2012. To compare the two side by side, visit the official Hybrid Breast Augmentation site (hybridbreast.co.kr), which documents 16 years of international academic evidence.

Practical differences vs. traditional implants

Beyond mechanistic differences, the following comparison summarizes the practical distinctions at the outcome level.

Comparison Gen 3 traditional implants Gen 4 BiVol
Material insertedSilicone implantADM · PDLLA · HA (replaced by autologous tissue)
Size customizationFixed factory sizesPrecisely tuned to the desired volume
FeelForeign-body sensation characteristic of implantsSimilar to natural breast tissue after remodeling
Capsular contracturePresentFundamentally reduced
Periodic replacementReview recommended around 10 yearsNot required — replaced by native tissue
Recovery2–4 weeks3–5 days
Asymmetry correctionLimitedLeft/right individually designed

The two points worth highlighting are the freedom of size customization and recovery time. Traditional implants force you to choose from fixed sizes such as 275cc or 300cc, whereas BiVol allows the shape and quantity of ADM to be finely tuned to each individual's anatomy. For patients with breast asymmetry, both sides can be independently designed — a meaningful advantage.

Surgeon's note

The 3–5 day recovery window applies to office-based work. Sutures are removed at day 7, light exercise resumes from week 3, and vigorous exercise from week 6. Individual recovery varies, so regular follow-up is essential.

Unlike Hybrid Augmentation, which combines an implant with autologous fat, BiVol contains no implant at all. Slender-framed patients and those bothered by foreign-body sensation tend to prefer this option. That said, if the goal is a very large augmentation (>500g), implant-based procedures may still be more suitable — so we recommend evaluating all options during your consultation.

The four biomaterials that complete BiVol

BiVol is not a single substance — it is completed by a combination of four biocompatible biomaterials. The ratio of each material is individually designed based on the patient's body type, desired volume, and tissue characteristics.

01
Acellular Dermal Matrix

ADM

Cellular components are removed to minimize immune response. A well-established biomaterial widely used in breast reconstruction.

02
Bio-degradable Polymer

PDLLA

A bio-degradable polymer that breaks down over time while stimulating the body to produce native collagen.

03
Hyaluronic Acid

High-purity HA

Provides immediate volume and hydration, completing a natural feel and soft contour.

04
Stem Cell Technology

Stem Cells

A cell-based technology that enhances graft survival during autologous fat transfer, added when a more natural finish is desired.

Is ADM truly safe?

This is the most common question. ADM has a long clinical track record in breast reconstruction and shows a very low risk of immune rejection thanks to its acellular processing3. Recent research shows that micronized ADM (mADM) does not act merely as a volume filler but as a regenerative scaffold that supports cell infiltration, neovascularization, and collagen remodeling4. A 2-year MRI-based volumetric study reported only a 3.7% volume loss with paste-type ADM, demonstrating long-term volume retention5. Bong Bong Plastic Surgery uses only certified ADM with domestic and international clinical data, and evaluates suitability for each patient through preoperative safety testing.

Who is BiVol suited for?

BiVol is particularly well suited to patients with the following concerns. Of course, suitability depends on individual body type and tissue characteristics, and the final decision is made only after a detailed consultation and diagnostic workup.

Surgical process and recovery timeline

BiVol at Bong Bong Plastic Surgery is not just a single procedure — it operates as a full system, from preoperative diagnostics through postoperative care. The entire process consists of five stages:

  1. STEP 01

    1-on-1 In-depth Consultation

    Body analysis, desired volume, and lifestyle are all considered. The chief director consults personally.

  2. STEP 02

    Safety Workup

    Blood testing, breast ultrasound, ECG, and other preoperative diagnostics to confirm surgical suitability.

  3. STEP 03

    3D Custom Design

    ADM shape, quantity, and material ratio are individually designed. Asymmetric cases are planned side-by-side.

  4. STEP 04

    Surgery (~60 min)

    Performed under general anesthesia. Surgery is completed within an hour, and same-day discharge is possible.

  5. STEP 05

    Postoperative Care

    Suture removal at day 7, follow-up assessments, and annual long-term tracking — all managed as one system.

Recovery timeline

Recovery varies from person to person, but the general timeline is as follows.

Curious if BiVol suits your body?

Diagnosed personally by the chief director of Bong Bong Plastic Surgery. Consultation and diagnostics are complimentary.

Book a Free Consultation →

Frequently Asked Questions

Here are the questions most commonly asked during BiVol consultations.

QHow does BiVol differ from traditional implant surgery?
The biggest difference is that BiVol uses no silicone implant. It combines biocompatible ADM (Acellular Dermal Matrix), PDLLA, and high-purity hyaluronic acid to precisely design the desired size. Over time, these materials are replaced by autologous tissue, fundamentally reducing the risks of foreign-body sensation, capsular contracture, and revision surgery.
QIs ADM a safe material?
ADM has a long clinical history in breast reconstruction. Its cellular components are removed, resulting in very low risk of immune rejection. Bong Bong Plastic Surgery uses only certified ADM with proven clinical data.
QHow long is recovery and return to daily life?
Surgery takes about 60 minutes and is same-day discharge. Return to office work is typically possible within 3–5 days. Light exercise resumes at week 3 and vigorous exercise at week 6. Sutures are removed at day 7.
QCan I get the exact size I want?
Yes. Unlike traditional implants that come in fixed sizes (e.g., 275cc, 300cc), BiVol combines ADM with autologous tissue to precisely design the volume you want. It is also well suited to correcting left–right asymmetry.
QHow much does BiVol cost?
Cost depends on body type, desired volume, and biomaterial quantity. A precise quote is provided during your consultation. Complimentary 1-on-1 consultations are available.
References
  1. Trademark BIVOL Trademark Registration — Korean Intellectual Property Office (KIPO) Trademark for the 4th-generation breast augmentation technique developed by Bong Bong Plastic Surgery. Registered in Korea, USA, EU (EUIPO), and China. Back
  2. Conference Park SS. BiVol — ECM-Based Regenerative Breast Augmentation. PRS KOREA 2025. International Congress of Plastic and Reconstructive Surgery Korea 2025. International presentation on 4th-generation breast augmentation using ECM-based regenerative materials. Back
  3. Clinical Cha YJ, Park EH. Early outcomes of volume replacement using paste-type micronized ADM in oncoplastic breast-conserving surgery. Gland Surgery (2026). Clinical study in 167 patients · 73 with paste mADM · equivalent operative time (83.0 vs 83.6 min) · 2.8% complication rate confirming safety · PMC13184350 · PubMed 42164680. PubMed → Back
  4. Mechanistic Development and Evaluation of an Injectable Acellular Dermal Matrix (SC Fill paste) for Breast Reconstruction. ACS Applied Bio Materials, 8(12):10827 (2026). Injectable mADM produced by supercritical CO₂ decellularization · reduced dsDNA and absent MHC-I indicating minimal immune response · fibroblast infiltration, neovascularization, and reduced capsular contracture · sustained MMP activity and collagen remodeling over 6 months. ACS Publications → Back
  5. Long-term Long-Term Shape and Volume Retention of ADM in Oncoplastic Breast-Conserving Surgery: 2-Year MRI-Based Volumetric Study. Journal of Clinical Medicine (MDPI, 2025). 172 patients · including 70 paste ADM/MegaFill® · MRI follow-up at 6, 12, and 24 months · 2-year volume loss of 3.7% (paste ADM superior to sheet ADM) · volume retention independent of radiotherapy (p=0.38). PMC12072617. PMC → Back

Closing thoughts

The goal of breast augmentation is, in the end, naturalness and confidence. BiVol does not simply refine the implant further — it redefines the material itself, pursuing both the invisible naturalness of a body that feels like your own and the reassurance of not needing revision surgery.

As with any surgery, no single procedure is right for everyone. Depending on your body type, desired volume, and recovery constraints, autologous fat augmentation, hybrid (implant + fat), or a traditional implant may be more suitable. That is why we recommend comparing all available options during consultation and selecting the approach best matched to your goals.

To go deeper on BiVol, review the ADM technology overview and PRS KOREA 2025 presentation materials at the official BiVol website. For hybrid augmentation, see the official Hybrid Breast Augmentation site. More clinical cases and columns are available on the Bong Bong Plastic Surgery Blog.